Risk of breast cancer among Norwegian women with visual impairment
Open Access
- 5 February 2001
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 84 (3) , 397-399
- https://doi.org/10.1054/bjoc.2000.1617
Abstract
Experimental studies suggest that melatonin has a protective effect against breast cancer. Exposure to light suppresses melatonin secretion, but to a lesser degree in totally blind persons. Breast cancer was investigated in a cohort of 15 412 Norwegian visually impaired women. The risk among totally blind women was 0.64 (95% CI = 0.21–1.49, 5 cases only), and for those who became blind before age of 65, the SIR was 0.51 (95% CI = 0.11–1.49). Our findings give support to the ‘melatonin hypothesis’. © 2001 Cancer Research Campaign http://www.bjcancer.comKeywords
This publication has 17 references indexed in Scilit:
- Inverse association between breast cancer incidence and degree of visual impairment in FinlandBritish Journal of Cancer, 1999
- Breast cancer, blindness and melatoninEuropean Journal Of Cancer, 1992
- Profound Bilateral Blindness and the Incidence of Breast CancerEpidemiology, 1991
- Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture.1988
- The role of oestrogens and progestagens in the epidemiology and prevention of breast cancerEuropean Journal of Cancer and Clinical Oncology, 1988
- Melatonin: A Coordinating Signal for Mammalian Reproduction?Science, 1985
- EFFECT OF MELATONIN ON B-16 MELANOMA GROWTH IN ATHYMIC MICE1985
- MELATONIN INHIBITION AND PINEALECTOMY ENHANCEMENT OF 7,12-DIMETHYLBENZ(A)ANTHRACENE-INDUCED MAMMARY-TUMORS IN THE RAT1981
- Light Suppresses Melatonin Secretion in HumansScience, 1980
- Age at first birth and breast cancer risk.1970